chlorothiazide

DRUG4 trials

Conditions

Cardiovascular DiseasesDiabetes Insipidus, NephrogenicHeart DiseasesHeart FailureHypertensionSafety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite AthletesVascular Diseases

Phase 3

Treatment of Hypertension

CompletedNCT00000484

National Heart, Lung, and Blood Institute (NHLBI)Cardiovascular Diseases, Heart Diseases, Hypertension +1

Start: 1966-04-30End: 1979-01-31Updated: 2013-11-26

Phase 4

Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure

CompletedNCT02606253

Vanderbilt UniversityHeart Failure

Start: 2016-02-29End: 2018-10-31Updated: 2019-11-08

Unknown Phase

Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus

CompletedNCT00004360

National Center for Research Resources (NCRR)Diabetes Insipidus, Nephrogenic

Start: 1995-09-30Updated: 2005-06-24

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Enrolling by invitationNCT07568574

Enhanced Emirates LimitedSafety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes

Start: 2026-03-12End: 2033-03-01Target: 60Updated: 2026-05-06

Related Papers

Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.